| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
TISSUE-SPECIFIC STEM CELLS |
ari
2
1 Institute of Immunology, University of Heidelberg, Im Neuenheimer Feld 305, D-69120 Heidelberg, Germany
2 Center for Physiology, Medical Faculty of the University of Cologne, Robert Koch Straße 39, 50931 Cologne, Germany
* To whom correspondence should be addressed. E-mail: cord.naujokat{at}med.uni-heidelberg.de.
 |
Abstract |
|---|
Highly ordered degradation of cell proteins by the ubiquitin-proteasome system, a sophisticated cellular proteolytic machinery, has been identified as a key regulatory mechanism in many eukaryotic cells. Accumulating evidence reveals that the ubiquitin-proteasome system is involved in the regulation of fundamental processes in mammalian stem and progenitor cells of embryonic, neural, hematopoietic and mesenchymal origin. Such processes, including development, survival, differentiation, lineage commitment, migration and homing, are directly controlled by the ubiquitin-proteasome system, either via proteolytic degradation of key regulatory proteins of signaling and gene expression pathways or via non-proteolytic mechanisms involving proteasomes itself or posttranslational modifications of target proteins by ubiquitin or other ubiquitin-like modifiers. Future characterization of the precise roles and functions of the ubiquitin-proteasome system in mammalian stem and early progenitor cells will improve our understanding of stem cell biology and may provide an experimental basis for the development of novel therapeutic strategies in regenerative medicine.
Key Words. Embryonic stem cells, Neural stem cells, Hematopoietic stem cells, Mesenchymal stem cells, Ubiquitin, Proteasome
This article has been cited by other articles:
|
|
 |
|
  R. W. Tsika, C. Schramm, G. Simmer, D. P. Fitzsimons, R. L. Moss, and J. Ji Overexpression of TEAD-1 in Transgenic Mouse Striated Muscles Produces a Slower Skeletal Muscle Contractile Phenotype J. Biol. Chem., December 26, 2008; 283(52): 36154 - 36167. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Okabe, T. Tauchi, and K. Ohyashiki Characteristics of Dasatinib- and Imatinib-Resistant Chronic Myelogenous Leukemia Cells Clin. Cancer Res., October 1, 2008; 14(19): 6181 - 6186. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. D. MacDonald, A. Knox, and D. Hansen Proteasomal Regulation of the Proliferation vs. Meiotic Entry Decision in the Caenorhabditis elegans Germ Line Genetics, October 1, 2008; 180(2): 905 - 920. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. J. Thompson, V. Jankovic, J. Gao, S. Buonamici, A. Vest, J. M. Lee, J. Zavadil, S. D. Nimer, and I. Aifantis Control of hematopoietic stem cell quiescence by the E3 ubiquitin ligase Fbw7 J. Exp. Med., June 9, 2008; 205(6): 1395 - 1408. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. D. Aragon, A. L. Rodriguez, O. Meirelles, S. Roy, G. S. Davidson, P. H. Tapia, C. Allen, R. Joe, D. Benn, and M. Werner-Washburne Characterization of Differentiated Quiescent and Nonquiescent Cells in Yeast Stationary-Phase Cultures Mol. Biol. Cell, March 1, 2008; 19(3): 1271 - 1280. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| STEM CELLS | THE ONCOLOGIST | CME | ALPHAMED PRESS JOURNALS |
